Home NDC 63323-960-10 Tigecycline
Product NDC 63323-960
Requested package NDC 63323-960-10
11-digit product format 633230960
Labeler code 63323
Product ID 63323-960_be02ec53-e514-4779-841b-22c6af4771af
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Tigecycline
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Fresenius Kabi USA, LLC
Application NDA205645
Marketing category NDA
Marketing start 2016-12-01
Marketing end 0000-00-00
Substance TIGECYCLINE
Active strength 50 mg/5mL
Pharmacologic classes Tetracycline-class Antibacterial [EPC],Tetracyclines [CS]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205645-001 TIGECYCLINE TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS RLD 2016-12-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2016-12-01 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2016-12-01 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2016-12-01 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2016-12-01 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N205645-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2016-12-01 cb3db0bc1861…
Observed Orange Book normalized TE history# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63323-960 TIGECYCLINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] 7 Legacy NDC 20240228_acf5dbe5-ca75-4300-816f-b3f4625f6e7d.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 63323-960-10 63323096010 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-960-10) > 5 mL in 1 VIAL, SINGLE-DOSE 2016-12-01 0000-00-00 No No Current